Gabapentin
NDC 69097-812, Gabapentin, tablet, from Cipla USA Inc..
- Product NDC
- 69097-812
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202764
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN600 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-812-02 | 69097081202 | 30 TABLET in 1 BOTTLE (69097-812-02) |
| 69097-812-07 | 69097081207 | 100 TABLET in 1 BOTTLE (69097-812-07) |
| 69097-812-12 | 69097081212 | 500 TABLET in 1 BOTTLE (69097-812-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7c3ac86f-b8f7-42bf-942a-db854d946e54
Use it
Look up 69097-812 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-812. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.